11 analysts have expressed a variety of opinions on Merit Medical Systems (NASDAQ:MMSI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a ...
Throughout the last three months, 17 analysts have evaluated Merit Medical Systems (NASDAQ:MMSI), offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of ...
Merit Medical Systems' shares have dropped due to an underwhelming 2024 guidance. The company has achieved steady growth under the leadership of founder Fred Lampropoulos, generating over $1 billion ...
Analyst Michael Matson from Needham reiterated a Buy rating on Merit Medical Systems (MMSI – Research Report) and keeping the price target at $109.00. Michael Matson has given his Buy rating due to a ...
Hosted on MSN
Wells Fargo Upgrades Merit Medical Systems (MMSI)
Fintel reports that on December 11, 2024, Wells Fargo upgraded their outlook for Merit Medical Systems (NasdaqGS:MMSI) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 6.44% Upside As ...
David Rescott, an analyst from Robert W. Baird, maintained the Buy rating on Merit Medical Systems (MMSI – Research Report). The associated price target remains the same with $96.00. David Rescott has ...
Acquisitions broaden Merit’s therapeutic platform with diverse dialysis product solutions and expand its access catheter offering Acquisitions projected to add approximately $30 million of revenue, on ...
MMSI has been the subject of several analyst reports. JPMorgan Chase & Co. assumed coverage on shares of Merit Medical Systems in a research report on Friday, March 28th. They set an “overweight” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback